<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[ExThera Medical Corporation 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=34813></link><description><![CDATA[ExThera Medical Corporation 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 02 May 2026 07:08:02 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2020/03/12_3554238800_20200327133611_9994851441.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[엑스테라의 친연성 혈액 필터, 코로나바이러스 감염증 환자 치료에 사용]]></title><link>https://www.newswire.co.kr/newsRead.php?no=903050</link><description><![CDATA[마티네스, 캘리포니아--(Business Wire/뉴스와이어)--엑스테라(ExThera)의 ‘세라프100 마이크로바인드 친연성 혈액 필터(Seraph®100 Microbind® Affinity Blood Filter)’(이하 ‘세라프100’)가 독일과 이탈리아 병원에서 코로나바이러스 감염증-19(COVID-19) 치료에 사용되기 시작했다.  ‘세라프100’은 프랑스와 미국에서도 곧 COVID-19 치료에 사용되기 시작할 것으로 예상된다.      ‘세라프100’은 혈액 내 병원균을 감소시키...]]></description><pubDate>Fri, 27 Mar 2020 13:54:42 +0900</pubDate></item><item><title><![CDATA[ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients]]></title><link>https://www.newswire.co.kr/newsRead.php?no=903049</link><description><![CDATA[MARTINEZ, Calif.--(Business Wire/Korea Newswire)--Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA.  Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical ...]]></description><pubDate>Fri, 27 Mar 2020 13:50:32 +0900</pubDate></item></channel></rss>